Open AccessLong-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents
Author(s) -
Silvia Goñi Esarte,
Regina Juanbeltz,
Jesús Castilla,
Ramón San Miguel,
J.I. Herrero,
José Manuel Zozaya
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6063/2018
Subject(s) - medicine , quality of life (healthcare) , visual analogue scale , observational study , depression (economics) , cirrhosis , anxiety , hepatitis c , prospective cohort study , gastroenterology , physical therapy , psychiatry , nursing , economics , macroeconomics
new direct-acting antivirals (DAAs) achieve high and sustained virological response (SVR) rates, although the long-term effect on patient health-related quality of life (HRQoL) is unknown. This study aimed to evaluate the impact of hepatitis C virus (HCV) clearance with DAAs on HRQoL after one year of follow-up.